Dynamic Technology Lab’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Dynamic Technology Lab’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-25,611	Closed	-$302K	–	1551
2017 Q3	$302K	Buy	25,611 +13,008	+103%	+$146K	0.05%	724
2017 Q2	$132K	Buy	+12,603	New	+$128K	0.02%	923
2016 Q3	–	Sell	-18,949	Closed	-$207K	–	1314
2016 Q2	$207K	Buy	+18,949	New	+$212K	0.06%	692

Other funds holding SCMP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Dynamic Technology Lab's SCMP Position: Q4 2017 in Review

Dynamic Technology Lab sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q4 2017, closing a stake of 25,611 shares — an estimated $302K sold.

Dynamic Technology Lab first reported a position in SCMP in Q2 2016 and held it in 3 quarters. The position peaked at $302K in Q3 2017. 188 funds tracked by Wall St. Rank hold SCMP as of Q4 2017.

Dynamic Technology Lab reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q4 2017 after selling out during the quarter.
Dynamic Technology Lab sold 25,611 Sucampo Pharmaceuticals, Inc. shares in Q4 2017, an estimated $302K.
Dynamic Technology Lab first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2016 and held it in 3 quarters.
Dynamic Technology Lab's Sucampo Pharmaceuticals, Inc. position peaked at $302K in Q3 2017.
188 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q4 2017.

Based on Dynamic Technology Lab's 13F filing for Q4 2017, filed 9 Feb 2018.